Get the tools used by (smart)2 investors.

Nutriband IncNASDAQCM:NTRB

United States / Healthcare / Pharmaceuticals

Join now and get access to the full platform

Exchange Data

Summary of Nutriband Inc

Hide this widget

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company’s lead product in development is AVERSA fentanyl, an abuse det...

Filings

Price History

Chart Gallery
Hide this widget
Loading chart...

Data Explorer

Peer Benchmarks

In the News

Finbox Fair Value

Hide this widget
What is Finbox Fair Value?
A stock's fair value is its real or underlying intrinsic worth.
Read more about Finbox's Fair Value methodology.
USD
Average
Upside
Uncertainty
You need an account to use this feature
Sign Up
Or
Log In

Financial Health

Financial Models for Nutriband Inc

Model Gallery
Hide this widget

Historical Financials

Full Financials
Hide this widget
(presentment in millions)Trailing Twelve MonthsFiscal Quarters
Period EndingJan-23Jan-24Oct-24Oct-23Oct-24
Income Statement
Revenue2.082.092.020.430.65
Operating Income(4.15)(4.87)(6.03)(1.72)(1.43)
Net Profit(4.48)(5.49)(6.85)(1.76)(1.36)
Diluted EPS-0.53-0.69-0.69-0.22-0.12
EBITDA(3.82)(4.58)(5.75)(1.66)(1.35)
Balance Sheet
Cash & ST Invest.1.990.495.701.275.70
Current Assets2.691.026.192.006.19
Total Assets9.467.52138.5213
Current Liabilities0.751.001.250.721.25
Total Liabilities0.881.081.312.811.31
Total Equity8.576.44115.7111
Total Debt0.190.240.202.250.20
Cash Flow Statement
Cash Flow Operations(2.99)(3.53)(4.11)(1.06)(1.01)
Cash From Investing(0.08)(0.05)(0.14)0.00(0.05)
Cash From Financing0.162.098.680.00(0.01)
Free Cash Flow(3.07)(3.58)(4.25)(1.06)(1.06)

Analyst Notes

March 21, 2025
Hide this widget
    All rights reserved. Terms Of Use